These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9050810)

  • 1. Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate.
    Crison JR; Weiner ND; Amidon GL
    J Pharm Sci; 1997 Mar; 86(3):384-8. PubMed ID: 9050810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Enzymes and Sodium Lauryl Sulfate on the Surface Tension of Dissolution Media: Toward Understanding the Solubility and Dissolution of Carvedilol.
    Hamed R; Alnadi SH; Awadallah A
    AAPS PharmSciTech; 2020 May; 21(5):146. PubMed ID: 32435989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant.
    Jinno J; Oh Dm; Crison JR; Amidon GL
    J Pharm Sci; 2000 Feb; 89(2):268-74. PubMed ID: 10688756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine.
    Crison JR; Shah VP; Skelly JP; Amidon GL
    J Pharm Sci; 1996 Sep; 85(9):1005-11. PubMed ID: 8877894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph.
    Rodríguez-Hornedo N; Murphy D
    J Pharm Sci; 2004 Feb; 93(2):449-60. PubMed ID: 14705201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the impact of sodium lauryl sulfate source variability on solid oral dosage form development.
    Qiang D; Gunn JA; Schultz L; Li ZJ
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1486-96. PubMed ID: 20545515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe.
    Aburub A; Risley DS; Mishra D
    Int J Pharm; 2008 Jan; 347(1-2):16-22. PubMed ID: 17656053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.
    Balakrishnan A; Rege BD; Amidon GL; Polli JE
    J Pharm Sci; 2004 Aug; 93(8):2064-75. PubMed ID: 15236455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant-mediated dissolution of metformin hydrochloride tablets: wetting effects versus ion pairs diffusivity.
    Desai D; Wong B; Huang Y; Ye Q; Tang D; Guo H; Huang M; Timmins P
    J Pharm Sci; 2014 Mar; 103(3):920-6. PubMed ID: 24549733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate.
    Guo Y; Wang C; Dun J; Du L; Hawley M; Sun CC
    J Pharm Sci; 2019 Jan; 108(1):516-524. PubMed ID: 30389564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of surfactants on the solubility and intrinsic dissolution rate of sparfloxacin.
    Mbah CJ; Ozuo CO
    Pharmazie; 2011 Mar; 66(3):192-4. PubMed ID: 21553649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
    Rao VM; Lin M; Larive CK; Southard MZ
    J Pharm Sci; 1997 Oct; 86(10):1132-7. PubMed ID: 9344170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium lauryl sulfate-mediated gelation on the suppressed dissolution of crystalline lurasidone hydrochloride and a strategy to mitigate the gelation.
    Lin Z; Pang Z; Zhang K; Qian Z; Liu Z; Zhang J; Gao Y; Wei Y
    Int J Pharm; 2022 Aug; 624():122035. PubMed ID: 35863597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin.
    Dave RH; Patel AD; Donahue E; Patel HH
    Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion.
    Patel AR; Joshi VY
    AAPS PharmSciTech; 2008; 9(2):583-90. PubMed ID: 18459049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.
    Lehto P; Kortejärvi H; Liimatainen A; Ojala K; Kangas H; Hirvonen J; Tanninen VP; Peltonen L
    Eur J Pharm Biopharm; 2011 Aug; 78(3):531-8. PubMed ID: 21329757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant.
    Sheng JJ; Kasim NA; Chandrasekharan R; Amidon GL
    Eur J Pharm Sci; 2006 Nov; 29(3-4):306-14. PubMed ID: 16982177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution-mediated phase transformation of haloperidol mesylate in the presence of sodium lauryl sulfate.
    Greco K; Bogner R
    AAPS PharmSciTech; 2011 Sep; 12(3):909-16. PubMed ID: 21732157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion.
    Yang B; Wu L; Ke J; Zhou L; Chen M; Li S; Feng X
    AAPS PharmSciTech; 2019 Feb; 20(3):102. PubMed ID: 30723877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Role of Sodium Lauryl Sulfate on the Biorelevant Solubility of a Combination of Poorly Water-Soluble Drugs Using High Throughput Experimentation and Mechanistic Absorption Modeling.
    Bahr MN; Modi D; Patel S; Campbell G; Stockdale G
    J Pharm Pharm Sci; 2019; 22(1):221-246. PubMed ID: 31219781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.